S1PR1 and early-onset autosomal dominant Alzheimer disease: Additionally, FTY720 exhibits neuroprotective effects in mouse models of Parkinson’s disease, while S1P1 agonist SEW2871 treatment improves cognitive function in rat models of Alzheimer’s disease [97, 98].